BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 23628889)

  • 1. Evidence for the widespread distribution of CRISPR-Cas system in the Phylum Cyanobacteria.
    Cai F; Axen SD; Kerfeld CA
    RNA Biol; 2013 May; 10(5):687-93. PubMed ID: 23628889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the Origin of Reverse Transcriptase-Using CRISPR-Cas Systems and Their Hyperdiverse, Enigmatic Spacer Repertoires.
    Silas S; Makarova KS; Shmakov S; Páez-Espino D; Mohr G; Liu Y; Davison M; Roux S; Krishnamurthy SR; Fu BXH; Hansen LL; Wang D; Sullivan MB; Millard A; Clokie MR; Bhaya D; Lambowitz AM; Kyrpides NC; Koonin EV; Fire AZ
    mBio; 2017 Jul; 8(4):. PubMed ID: 28698278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR-Cas systems in multicellular cyanobacteria.
    Hou S; Brenes-Álvarez M; Reimann V; Alkhnbashi OS; Backofen R; Muro-Pastor AM; Hess WR
    RNA Biol; 2019 Apr; 16(4):518-529. PubMed ID: 29995583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cas1 and Cas2 From the Type II-C CRISPR-Cas System of
    He Y; Wang M; Liu M; Huang L; Liu C; Zhang X; Yi H; Cheng A; Zhu D; Yang Q; Wu Y; Zhao X; Chen S; Jia R; Zhang S; Liu Y; Yu Y; Zhang L
    Front Cell Infect Microbiol; 2018; 8():195. PubMed ID: 29951376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic prediction of genes functionally linked to CRISPR-Cas systems by gene neighborhood analysis.
    Shmakov SA; Makarova KS; Wolf YI; Severinov KV; Koonin EV
    Proc Natl Acad Sci U S A; 2018 Jun; 115(23):E5307-E5316. PubMed ID: 29784811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How type II CRISPR-Cas establish immunity through Cas1-Cas2-mediated spacer integration.
    Xiao Y; Ng S; Nam KH; Ke A
    Nature; 2017 Oct; 550(7674):137-141. PubMed ID: 28869593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR-Cas: evolution of an RNA-based adaptive immunity system in prokaryotes.
    Koonin EV; Makarova KS
    RNA Biol; 2013 May; 10(5):679-86. PubMed ID: 23439366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic Characterization of Cyanophage vB_AphaS-CL131 Infecting Filamentous Diazotrophic Cyanobacterium
    Šulčius S; Šimoliūnas E; Alzbutas G; Gasiūnas G; Jauniškis V; Kuznecova J; Miettinen S; Nilsson E; Meškys R; Roine E; Paškauskas R; Holmfeldt K
    Appl Environ Microbiol; 2019 Jan; 85(1):. PubMed ID: 30367000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adaptation and modification of three CRISPR loci in two closely related cyanobacteria.
    Hein S; Scholz I; Voß B; Hess WR
    RNA Biol; 2013 May; 10(5):852-64. PubMed ID: 23535141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viruses Infecting a Freshwater Filamentous Cyanobacterium (Nostoc sp.) Encode a Functional CRISPR Array and a Proteobacterial DNA Polymerase B.
    Chénard C; Wirth JF; Suttle CA
    mBio; 2016 Jun; 7(3):. PubMed ID: 27302758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phylogenomics of Cas4 family nucleases.
    Hudaiberdiev S; Shmakov S; Wolf YI; Terns MP; Makarova KS; Koonin EV
    BMC Evol Biol; 2017 Nov; 17(1):232. PubMed ID: 29179671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survey of clustered regularly interspaced short palindromic repeats and their associated Cas proteins (CRISPR/Cas) systems in multiple sequenced strains of Klebsiella pneumoniae.
    Ostria-Hernández ML; Sánchez-Vallejo CJ; Ibarra JA; Castro-Escarpulli G
    BMC Res Notes; 2015 Aug; 8():332. PubMed ID: 26238567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The basic building blocks and evolution of CRISPR-CAS systems.
    Makarova KS; Wolf YI; Koonin EV
    Biochem Soc Trans; 2013 Dec; 41(6):1392-400. PubMed ID: 24256226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unprecedented Diversity of Unique CRISPR-Cas-Related Systems and Cas1 Homologs in Asgard Archaea.
    Makarova KS; Wolf YI; Shmakov SA; Liu Y; Li M; Koonin EV
    CRISPR J; 2020 Jun; 3(3):156-163. PubMed ID: 33555973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Classification and evolution of type II CRISPR-Cas systems.
    Chylinski K; Makarova KS; Charpentier E; Koonin EV
    Nucleic Acids Res; 2014 Jun; 42(10):6091-105. PubMed ID: 24728998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current understanding of the cyanobacterial CRISPR-Cas systems and development of the synthetic CRISPR-Cas systems for cyanobacteria.
    Pattharaprachayakul N; Lee M; Incharoensakdi A; Woo HM
    Enzyme Microb Technol; 2020 Oct; 140():109619. PubMed ID: 32912679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Why so rare if so essentiel: the determinants of the sparse distribution of CRISPR-Cas systems in bacterial genomes].
    Bernheim A
    Biol Aujourdhui; 2017; 211(4):255-264. PubMed ID: 29956652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spontaneous CRISPR loci generation in vivo by non-canonical spacer integration.
    Nivala J; Shipman SL; Church GM
    Nat Microbiol; 2018 Mar; 3(3):310-318. PubMed ID: 29379209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A guild of 45 CRISPR-associated (Cas) protein families and multiple CRISPR/Cas subtypes exist in prokaryotic genomes.
    Haft DH; Selengut J; Mongodin EF; Nelson KE
    PLoS Comput Biol; 2005 Nov; 1(6):e60. PubMed ID: 16292354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR adaptive immune systems of Archaea.
    Vestergaard G; Garrett RA; Shah SA
    RNA Biol; 2014; 11(2):156-67. PubMed ID: 24531374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.